B of A Securities Initiates Coverage On Apnimed with Buy Rating, Announces Price Target of $41
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsInitiationPrice Target
B of A Securities analyst Jason Gerberry initiates coverage on Apnimed (NASDAQ:APMD) with a Buy rating and announces Price Target of $41.
B of A Securities analyst Jason Gerberry initiates coverage on Apnimed (NASDAQ:APMD) with a Buy rating and announces Price Target of $41.